ShapeTX is Drug Discovery in United States that focus on rare genetic diseases business. Founded in 2018. They cover business area such as developer, neurodegenerative disorder, oncology, metabolic, rare genetic disease, vivo targeting, modification, ribonucleic acid, RNA, adenosine deaminase, suppressor trnas, immune-stealth adeno-associate virus, medical company, immunogenicity.
2018
( 6 years old in 2024 )
Rare Genetic Diseases
-
219 Terry Ave North
Suite 100
Seattle, WA 98109
United States
Private
developerneurodegenerative disorderoncologymetabolicrare genetic diseasevivo targetingmodificationribonucleic acidRNAadenosine deaminasesuppressor trnasimmune-stealth adeno-associate virusmedical companyimmunogenicity
* We use standard office opening hours in near ShapeTX's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
ShapeTX is Drug Discovery business from United States that founded in 2018 (6 years old in 2024), ShapeTX business is focusing on Rare Genetic Diseases.
ShapeTX headquarter office and corporate office address is located in 219 Terry Ave North Suite 100 Seattle, WA 98109 United States.
ShapeTX was founded in United States.
In 2024, ShapeTX is currently focus on rare genetic diseases sector.
Above is snippet of Google Trends for "rare genetic diseases" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with ShapeTX, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
